HPPH and PDT for Pleural Malignancy
NCT01673074
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Pleural Malignancy
Interventions
DRUG:
(PDT) Photodynamic therapy
Sponsor
Abramson Cancer Center at Penn Medicine